SCHEMBL5950000

SCHEMBL5950000

CCN(Cc1cn(C)c2ccccc12)C(=O)/C=C/c1cnc2c(c1)CN(C(=O)OCc1ccccc1)CC(=O)N2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5950016 1.00 — —
SCHEMBL1253887 0.92 — —
SCHEMBL1253882 0.92 — —
SCHEMBL10266873 0.80 — —
SCHEMBL1254061 0.80 — —
Hydrochloric Acid SCHEMBL1254065 0.79 — —
Hydrochloric Acid SCHEMBL1254058 0.79 — —
SCHEMBL1254018 0.78 — —
SCHEMBL1254009 0.78 — —
SCHEMBL5950011 0.78 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060183908-A1 inhibitors of bacterial enzymes such as (E)-3-(3,3-Dimethyl-2-oxo-2,3,4,5-tetrahydro-1H-pyrido [2,3-e][1,4]diazepin-7-yl)-N-methyl-N-(3-methyl-benzofuran-2-ylmethyl)acrylamide, used as antibiotics AFFINIUM PHARMACEUTICALS, INC. (CA) 2006-08-17 — — US disclosed
Send feedback